`
`
`
`
`
`
`
`
`UNITED STATES INTERNATIONAL TRADE COMMISSION
`Washington, D.C.
`
`
`In the Matter of
`
`CERTAIN LIGHT-BASED
`PHYSIOLOGICAL MEASUREMENT
`DEVICES AND COMPONENTS
`THEREOF
`
`
`
`
`
`
`Investigation No. 337-TA-1276
`
`LIMITED EXCLUSION ORDER
`
`The United States International Trade Commission (“Commission”) has determined that
`
`there is a violation of section 337 of the Tariff Act of 1930, as amended (19 U.S.C. § 1337), in
`
`the unlawful importation, sale for importation, or sale within the United States after importation
`
`by respondent Apple, Inc. of Cupertino, California (“Respondent”) of certain light-based
`
`physiological measurement devices and components thereof (as defined in paragraph 2 below)
`
`that infringe one or more of claims 22 and 28 of U.S. Patent No. 10,912,502 and claims 12, 24,
`
`and 30 of U.S. Patent No. 10,945,648 (“Asserted Patents”).
`
`Having reviewed the record in this investigation, including the written submissions of the
`
`parties, the Commission has made its determinations on the issues of remedy, the public interest,
`
`and bonding. The Commission has determined that the appropriate form of relief is a limited
`
`exclusion order prohibiting the unlicensed entry of infringing light-based physiological
`
`measurement devices and components thereof manufactured by or on behalf of Respondent or
`
`any of its affiliated companies, parents, subsidiaries, agents, or other related business entities, or
`
`its successors or assigns.
`
`The Commission has also determined that the public interest factors enumerated in
`
`19 U.S.C. § 1337(d) do not preclude the issuance of the limited exclusion order, and that the
`
`
`
`bond during the period of Presidential review shall be in the amount of zero percent (0%, i.e., no
`
`bond) of the entered value of the entered value of the articles subject to this Order.
`
`Accordingly, the Commission hereby ORDERS that:
`
`1.
`
`Light-based physiological measurement devices and components thereof that
`
`infringe one or more of claims 22 and 28 of U.S. Patent No. 10,912,502 and claims 12, 24, and
`
`30 of U.S. Patent No. 10,945,648 and are manufactured abroad by, or on behalf of, or imported
`
`by or on behalf of Respondent or any of its affiliated companies, parents, subsidiaries, agents, or
`
`other related business entities, or its successors or assigns, are excluded from entry for
`
`consumption into the United States, entry for consumption from a foreign-trade zone, or
`
`withdrawal from a warehouse for consumption, for the remaining terms of the Asserted Patents,
`
`except under license from, or with the permission of, the patent owner or as provided by law; and
`
`except for parts necessary to service and repair covered products purchased by consumers prior
`
`to the date this Order becomes final within the meaning of 19 U.S.C. § 1337(j)(4), and except for
`
`covered products that are replacements for covered products purchased by consumers prior to the
`
`date this Order becomes final within the meaning of 19 U.S.C. § 1337(j)(4), provided that
`
`replacement is pursuant to a warranty for the replaced article.
`
`2.
`
`The light-based physiological measurement devices and components thereof
`
`subject to this exclusion order (i.e., “covered articles”) are as follows: wearable electronic
`
`devices with light-based pulse oximetry functionality and components thereof.
`
`3.
`
`Notwithstanding paragraph 1 of this Order, covered articles are entitled to entry
`
`into the United States for consumption, entry for consumption from a foreign trade zone, or
`
`withdrawal from a warehouse for consumption, under bond in the amount of zero percent (0%,
`
`i.e., no bond) of their entered value, pursuant to subsection (j) of section 337 (19 U.S.C.
`
`
`
`2
`
`
`
`§ 1337(j)) and the Presidential Memorandum for the United States Trade Representative of July
`
`21, 2005 (70 Fed. Reg. 43,251), from the day after this Order is received by the United States
`
`Trade Representative until such time as the United States Trade Representative notifies the
`
`Commission that this Order is approved or disapproved but, in any event, not later than sixty (60)
`
`days after the receipt of this Order. All entries of covered articles made pursuant to this
`
`paragraph are to be reported to U.S. Customs and Border Protection (“CBP”), in advance of the
`
`date of the entry, pursuant to procedures CBP establishes.
`
`4.
`
`At the discretion of CBP and pursuant to the procedures it establishes, persons
`
`seeking to import articles may be required to certify that they are familiar with the terms of this
`
`Order, that they have made appropriate inquiry, and thereupon state that, to the best of their
`
`knowledge and belief, the products being imported are not excluded from entry under paragraph
`
`1 of this Order. At its discretion, CBP may require persons who have provided the certification
`
`described in this paragraph to furnish such records or analyses as are necessary to substantiate
`
`the certification.
`
`5.
`
`In accordance with 19 U.S.C. § 1337(l), the provisions of this Order shall not
`
`apply to covered articles that are imported by and for the use of the United States, or imported
`
`for and to be used for, the United States with the authorization or consent of the Government.
`
`6.
`
`The Commission may modify this Order in accordance with the procedures
`
`described in Rule 210.76 of the Commission’s Rules of Practice and Procedure (19 C.F.R.
`
`§ 210.76).
`
`7.
`
`The Secretary shall serve copies of this Order upon each party of record in this
`
`investigation that has retained counsel or otherwise provided a point of contact for electronic
`
`service and upon CBP.
`
`
`
`3
`
`
`
`8.
`
`Notice of this Order shall be published in the Federal Register.
`
`By order of the Commission.
`
`
`
`
`
`Lisa R. Barton
`Secretary to the Commission
`
`
`
`
`Issued: October 26, 2023
`
`
`
`4
`
`